Bliss GVS Pharma: The Outcome of Board Meeting which was held on today i.e. October 29, 2026
Bliss GVS Pharma (BLISSGVS) filed a disclosure titled "The Outcome of Board Meeting which was held on today i.e. October 29, 2026". The company is valued at about ₹7,221 crore.
What happened
Bliss GVS Pharma (BLISSGVS) filed a disclosure with the exchanges on 29 October 2026 at 05:17 PM titled "The Outcome of Board Meeting which was held on today i.e. October 29, 2026".
Company snapshot
Bliss GVS Pharma is a small-cap company, with a market value of about ₹7,221 crore.
The stock last traded at ₹680.9, against a 52-week range of ₹118–₹739.9 (8.0% below the high).
Before this filing the shares had moved −8.0% over the month and +42.2% over three months. Average daily turnover over the last 20 sessions was about ₹11.88 crore.
Promoters held 35.01% at the end of Q1 FY27, down 0.35% points from the previous quarter. Foreign institutions owned 8.07% and domestic institutions 9.47%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 207 | 43 | 4.08 |
| Q2 FY26 | 244 | 27.3 | 2.58 |
| Q3 FY26 | 218 | 23.3 | 2.2 |
| Q4 FY26 | 257 | 35.6 | 3.37 |
| Q1 FY27 | 286 | 50.1 | 4.73 |
What history shows
BCEIE's records show 4 previous board meeting filings from the company since May 2026.
After those filings, the stock fell 1.3% on average the next trading day and was up 1.7% on average after five days (3 filings with price data).
Market-wide, 2,948 board meeting filings with an impact score of 50 or more saw an average next-day move of −0.1%, with 43% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 1 Oct 2026 | Herewith the outcome of the Board Meeting held today i.e. Thursday,… | −1.0% | −2.0% |
| 5 Aug 2026 | Board Meeting Intimation for Intimation Of Board Meeting To Be Held… | −3.9% | +3.4% |
| 3 Jul 2026 | Board Meeting Outcome for Outcome Of Board Meeting Held On Friday,… | +1.2% | +3.6% |
What to watch
- 29 October 2026: Board meeting — Financial Results/Other business matters.
In the news
Recent coverage elsewhere (links open the original publisher):
- Anupam Rasayan revises Bliss GVS open offer timeline, IDC recommends tender
- Anupam Rasayan India acquires controlling stake in Bliss GVS Pharma; Kanga & Co advises sellers
- We Ran A Stock Scan For Earnings Growth And Bliss GVS Pharma (NSE:BLISSGVS) Passed With Ease
- Bliss GVS Pharma BLISSGVS Postal Ballot Notice October 2026
- Bliss GVS Pharma seeks shareholder approval for three new directors
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.